Evaluation of Ultrasensitive Chromosomal Aneuploidy Detection for Detecting Minimal Residual Disease in Multiple Myeloma
NCT04122092
·
clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DIAGNOSTIC_TEST:
The level of plasma cfDNA CINs
Sponsor
Shanghai Changzheng Hospital